Osmille D (Colecalciferol, Calcium Carbonate)

Colecalciferol is converted in the liver to 25‑hydroxyvitamin D and then to the active hormone 1,25‑dihydroxyvitamin D. This hormone binds to vitamin D receptors in the intestine, stimulating the synthesis of calcium‑binding proteins and increasing the efficiency of dietary calcium absorption.

The appropriate dose of Osmille D is determined by the prescribing healthcare professional based on the patient’s age, baseline calcium and vitamin D status, underlying medical conditions, and any concurrent medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Osmille D may be used during pregnancy or lactation only if the prescriber judges that the potential benefits outweigh any possible risks. Vitamin D and calcium are important for fetal bone development, but dosing should be individualized and supervised by a healthcare provider.

To order Osmille D, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Osmille D combines colecalciferol and calcium carbonate in a single oral formulation, offering both vitamin D3 and a readily absorbable source of elemental calcium. Compared with products that contain only calcium or only vitamin D, Osmille D provides a convenient dual‑nutrient approach, which can simplify dosing and improve adherence when both nutrients are needed.

Store Osmille D at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture, excessive heat and direct sunlight. Do not store in the refrigerator or freezer, as this may affect tablet integrity.

Osmille D is taken orally, usually with a glass of water. It can be swallowed with or without food, unless the prescribing clinician advises otherwise. Patients should follow the dosage schedule provided by their healthcare professional.

The most serious risks include hypercalcemia, which can cause confusion, cardiac arrhythmias, or kidney stones, and rare cases of severe allergic reactions such as anaphylaxis. Prompt medical attention is required if symptoms of high calcium levels or allergic responses develop.

Individuals with known hypersensitivity to colecalciferol, calcium carbonate, or any excipients in the product should avoid Osmille D. Patients with hypercalcemia, severe renal impairment, or certain granulomatous diseases should not use it unless specifically directed by a physician.